Quantitative magnetic resonance imaging for chronic liver disease

Area of Science:

• Hepatology
• Radiology
• Biomarkers

Background:

• Chronic liver disease (CLD) prevalence and mortality have risen globally.
• Liver biopsy, the current standard, has invasive limitations for diagnosis and monitoring.
• Non-invasive biomarkers are crucial for accurate CLD assessment.

Purpose of the Study:

• To review the limitations of liver biopsy for CLD.
• To discuss the development and application of MRI-based biomarkers for CLD.
• To highlight MRI's potential for quantitative assessment of liver components.

Main Methods:

• Review of current literature on liver biopsy and MRI techniques.
• Discussion of MRI-based biomarkers for liver iron, fat, fibrosis, and inflammation.
• Analysis of MRI's accuracy, precision, and quantitative capabilities.

Main Results:

• MRI-based biomarkers provide accurate and precise quantitative assessment of liver components.
• MRI overcomes the invasiveness and limitations associated with liver biopsy.
• Current MRI techniques show promise for diagnosing and monitoring CLD.

Conclusions:

• MRI-based biomarkers represent a significant advancement in CLD assessment.
• Non-invasive MRI offers a safer and potentially more effective alternative to liver biopsy.
• Further research and clinical integration of MRI biomarkers are warranted for improved CLD management.